EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Genetic and Biochemical Characterization of Hyperphenylalaninemia Based on Expanded Neonatal Screening Data from 2023 to 2024 in the Russian Federation

Ekaterina E Lotnik iD, Alena L Chukhrova, Nina V Ryadninskaya, Varvara A Kadnikova, Ekaterina Y Zakharova, Galina V Baydakova, Andrey R Osadchii iD, Inga V Anisimova, Sergei V Voronin, Sergey I Kutsev, Kirill V Savostyanov iD, Fanil S Bilalov und 10 weitere

International Journal of Molecular Sciences · 21.06.2026 · 27 (12) · 5597

DOI: 10.3390/ijms27125597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2026. Verfasst von Ekaterina E Lotnik und 21 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Phenylketonurias, Neonatal Screening, Phenylalanine Hydroxylase. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since January 2023, the Russian Federation has implemented expanded neonatal screening for 36 hereditary disorders, which has changed the diagnostic algorithm for hyperphenylalaninemia/phenylketonuria (HPA/PKU) by introducing tandem mass spectrometry (MS/MS) on the second day of life, followed by confirmatory biochemical and molecular testing in newborns at risk. We analyzed 1247 newborns aged 5–15 days with elevated phenylalanine levels (≥120 µmol/L) and a phenylalanine to tyrosine ratio of at least 1 detected during the first stage of screening using MS/MS. At the reference center, newborns underwent repeat biochemical testing and stepwise molecular analysis of HPA-associated genes. Two pathogenic variants in HPA-associated genes were identified in 538 newborns, including 534 newborns with biallelic pathogenic variants in PAH and 4 with BH4-deficient forms (PTS, QDPR). The incidence of molecularly confirmed HPA was 1:4518 newborns (95% CI: 1:4152–1:4925). The PAH variant spectrum was dominated by p.Arg408Trp (c.1222C>T) (33.4%). Genotype-based analysis indicated that 73 newborns (13.7%) were likely responsive to cofactor therapy, whereas 222 (41.6%) were potentially responsive. These findings define the molecular epidemiology of HPA in Russia and support early genetic stratification for diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasNeonatal ScreeningPhenylalanine HydroxylaseHumansRussiaInfant, NewbornPhenylalanineTandem Mass SpectrometryFemaleMutation

Stichwörter der Autor:innen

BH4PAHhyperphenylalaninemiamolecular epidemiologyneonatal screeningphenylalanine hydroxylasephenylketonuriatandem mass spectrometry

Substanzen

Phenylalanine HydroxylasePhenylalanine

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia.
  • National Medical Research Centre for Children's Health, Lomonosovskiy Prospekt, 2 b.1, 119991 Moscow, Russia.
  • Republican Medical Genetic Centre, Gafuri St., 74, 450076 Ufa, Russia.
  • Diagnostic Centre (Medical Genetic), Tobolskaya St., 5A, 194044 Saint-Petersburg, Russia.
  • National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Akademika Oparina St., 4, 117997 Moscow, Russia.
  • Scientific Centre for Family Health and Human Reproduction Problems, Timiryazeva St., 16, 664003 Irkutsk, Russia.

ORCID-Profile: Ekaterina E Lotnik, Andrey R Osadchii, Kirill V Savostyanov, Alexander L Koroteev, Tatyana A Golikhina, Olga A Shchagina

Zitieren

APA

Lotnik, E. E., Chukhrova, A. L., Ryadninskaya, N. V., Kadnikova, V. A., Zakharova, E. Y., Baydakova, G. V., Osadchii, A. R., Anisimova, I. V., Voronin, S. V., Kutsev, S. I., Savostyanov, K. V., Bilalov, F. S., Koroteev, A. L., Trofimov, D. Y., Bairova, T. A., Seitova, G. N., Mordanov, S. V., Matulevich, S. A., Golikhina, T. A., …, & Shchagina, O. A. (2026). Molecular Genetic and Biochemical Characterization of Hyperphenylalaninemia Based on Expanded Neonatal Screening Data from 2023 to 2024 in the Russian Federation. International Journal of Molecular Sciences, 27(12), 5597. https://doi.org/10.3390/ijms27125597

Vancouver

Lotnik EE, Chukhrova AL, Ryadninskaya NV, Kadnikova VA, Zakharova EY, Baydakova GV, et al. Molecular Genetic and Biochemical Characterization of Hyperphenylalaninemia Based on Expanded Neonatal Screening Data from 2023 to 2024 in the Russian Federation. International Journal of Molecular Sciences. 2026;27(12):5597. doi:10.3390/ijms27125597

BibTeX
@article{Lotnik2026,
  author = {Lotnik, Ekaterina E and Chukhrova, Alena L and Ryadninskaya, Nina V and Kadnikova, Varvara A and Zakharova, Ekaterina Y and Baydakova, Galina V and Osadchii, Andrey R and Anisimova, Inga V and Voronin, Sergei V and Kutsev, Sergey I and Savostyanov, Kirill V and Bilalov, Fanil S and Koroteev, Alexander L and Trofimov, Dmitry Y and Bairova, Tatyana A and Seitova, Gulnara N and Mordanov, Sergei V and Matulevich, Svetlana A and Golikhina, Tatyana A and Nikolaeva, Elena B and Polyakov, Aleksander V and Shchagina, Olga A},
  title = {Molecular Genetic and Biochemical Characterization of Hyperphenylalaninemia Based on Expanded Neonatal Screening Data from 2023 to 2024 in the Russian Federation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5597},
  doi = {10.3390/ijms27125597}
}
Kostenlos starten →